Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. An antiplatelet drug.

Etymologies

Sorry, no etymologies found.

Examples

  • Other drugs tied to venoms include Schering-Ploughs Integrilin (eptifibatide), to treat acute coronary syndrome.

    Archive 2007-04-01

  • She was anticoagulated with heparin and eptifibatide.

    BioMed Central - Latest articles

  • At 37°C, though, the agent showed no significant effect on platelet aggregation, unlike abciximab and eptifibatide.

    MedPageToday.com - medical news plus CME for physicians

  • In human and mouse blood samples, the experimental agent appeared to inhibit fibrinogen binding to platelets as well as abciximab (ReoPro) and eptifibatide (Integrilin) at 22°C

    MedPageToday.com - medical news plus CME for physicians

  • In this case, Teva filed an ANDA for generic versions of Integrelin (eptifibatide), an antiplatelet drug that is used to reduce the risk of acute cardiac ischemic events.

    SeekingAlpha.com: Home Page

  • ACC: No Benefit Found From Early Eptifibatide in Acute Coronary Syndrome ORLANDO -- In patients who have acute coronary syndrome without ST-segment elevation who are undergoing percutaneous intervention, the timing of the administration of eptifibatide

    MedPageToday.com - medical news plus CME for physicians

  • Tirofiban [tye-roe-FYE-ban] is not a peptide, but it blocks the same site as eptifibatide.

    The Highlight HEALTH Network

  • Fung AY, Saw J, Starovoytov A, et al. Abbreviated infusion of eptifibatide after successful coronary intervention the BRIEF-PCI (brief infusion of eptifibatide following percutaneous coronary intervention) randomized trial.

    theHeart.org

  • American Heart Association 2007 Scientific Sessions, found that a shortened, less-than-two-hour infusion of the GP IIb / IIIa inhibitor eptifibatide (Integrelin, Schering-Plough) following nonemergency PCI is just as effective as the standard 18-hour infusion of the drug.

    theHeart.org

  • M. Sc., of the Denver VA M.dical Center and University of Colorado Denver, and colleagues examined the use of the contraindicated/not-recommended antithrombotic agents enoxaparin and eptifibatide among dialysis patients undergoing percutaneous coronary intervention (PCI) and their association with outcomes.

    Health News from Medical News Today

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.